Aché Laboratórios Farmacêuticos S.A.;Aché International (BVI) Ltd.
发明人:
申请号：
EP15181103.1
公开号：
EP3130339A1
申请日:
2015.08.14
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to a compound for use in the treatment of comorbid anxiety disorder and depression disorder, as well as for preventing depression disorders in individuals affected by anxiety disorders, wherein the compound is selected from the group presenting the general formula (I):wherein R1 is -OCH3 or -CNor suitable pharmaceutical salts, hydrates or anhydrates thereof.
